Oxbryta (Voxelotor) Lawsuit 2026: What Sickle Cell Families Need to Know
Pfizer voluntarily withdrew Oxbryta worldwide in September 2024 after postmarketing data showed increased deaths, strokes, and vaso-occlusive crises. Here is what affected patients and families need to know about the ongoing litigation, 2027 trial dates, and their legal rights.
Oxbryta lawsuit voxelotor sickle cell disease